Infinity Pharmaceuticals Inc (INFI)

Add to Watchlists
Create an Alert
1.15 +0.01  +0.88% NASDAQ Oct 17, 20:00 Delayed 2m USD

Infinity Pharmaceuticals Total Liabilities (Quarterly):

38.87M for June 30, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Total Liabilities (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Total Liabilities (Quarterly) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2019 38.87M
March 31, 2019 35.34M
Dec. 31, 2018 7.756M
Sept. 30, 2018 6.141M
June 30, 2018 5.71M
March 31, 2018 4.569M
Dec. 31, 2017 11.62M
Sept. 30, 2017 10.90M
June 30, 2017 31.94M
March 31, 2017 29.82M
Dec. 31, 2016 43.20M
Sept. 30, 2016 49.78M
June 30, 2016 68.46M
March 31, 2016 178.85M
Dec. 31, 2015 190.26M
Sept. 30, 2015 199.62M
June 30, 2015 153.62M
March 31, 2015 146.56M
Dec. 31, 2014 159.67M
Sept. 30, 2014 151.31M
June 30, 2014 27.10M
March 31, 2014 26.73M
Dec. 31, 2013 29.44M
Sept. 30, 2013 30.55M
June 30, 2013 27.82M
   
March 31, 2013 24.13M
Dec. 31, 2012 25.46M
Sept. 30, 2012 18.46M
June 30, 2012 116.44M
March 31, 2012 107.96M
Dec. 31, 2011 109.06M
Sept. 30, 2011 69.63M
June 30, 2011 66.42M
March 31, 2011 65.89M
Dec. 31, 2010 75.08M
Sept. 30, 2010 63.69M
June 30, 2010 51.34M
March 31, 2010 52.61M
Dec. 31, 2009 67.01M
Sept. 30, 2009 54.48M
June 30, 2009 56.58M
March 31, 2009 56.79M
Dec. 31, 2008 40.32M
Sept. 30, 2008 61.49M
June 30, 2008 64.71M
March 31, 2008 65.78M
Dec. 31, 2007 78.58M
Sept. 30, 2007 78.53M
June 30, 2007 81.17M
March 31, 2007 84.13M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Total Liabilities

Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.

Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.

Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.

Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More

Advertisement

Total Liabilities (Quarterly) Benchmarks

Benchmarks
Bristol-Myers Squibb Co 39.01B
Arcus Biosciences Inc 42.33M
Merck & Co Inc 56.23B

Total Liabilities (Quarterly) Range, Past 5 Years

Minimum 4.569M Mar 2018
Maximum 199.62M Sep 2015
Average 72.25M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.